About Christoph Schäfer

This author has not yet filled in any details.
So far Christoph Schäfer has created 12 blog entries.

CIS Pharma presenting ADC drug carrier technology at Swiss Biotech Day 2017

Basel, Switzerland, May 4th 2017 -- CIS Pharma presents its ADC drug carrier technology at Swiss Biotech Day 2017, scheduled for 14:10 during the Emerging Companies Streams. CIS Pharma ADC [...]

By | Mai 1st, 2017|ADC, Cellophil, Corporate|0 Comments

CIS Pharma appoints Dr. Christophe Thommen as new head of research and laboratory operations

Bubendorf, Switzerland, December 2016 -- CIS Pharma welcomes Dr. Christophe Thommen, who will lead the research team as the new head of research and laboratory operations. Christophe is an expert [...]

By | Dezember 1st, 2016|ADC, Cellophil, Corporate|0 Comments

CIS Pharma’s solubilization technology comprising cyclosporine A has entered proof of concept phase

Bubendorf, Switzerland October 2016 - CIS Pharma’s novel solubilization strategy for hydrophobic drugs has successfully reached the proof of concept phase. The Cellophil® Smart Polymer technology platform creates water-soluble formulations [...]

By | Oktober 1st, 2016|Cellophil, solubilization technology|0 Comments

CIS Pharma has successfully concluded the development of novel contact lens coating technology

Bubendorf, Switzerland, September 2016 -- CIS Pharma has concluded the development of a novel contact lens coating technology based on the Cellophil® Smart Polymer platform. The technology has been shown [...]

By | September 1st, 2016|Cellophil, ContactlensCoating|0 Comments

CIS Pharma to launch new web presence

Bubendorf, Switzerland, August 2016 -- CIS Pharma’s new company website is online. The site was established in collaboration with SKYWEB, a fast-growing start-up incorporated in close proximity to CIS Pharma. [...]

By | August 1st, 2016|Corporate|0 Comments

CIS Pharma has developed contact lens care products based on its new patented technology platform

Bubendorf, Switzerland, June 2016 -- CIS Pharma has developed a novel multipurpose solution for contact lenses. With over 25 years of experience and a track record of several lens care [...]

By | Juni 1st, 2016|Lenscareproducts|0 Comments

CIS Pharma announces the first milestones in its ADC research program are achieved

Bubendorf, Switzerland, January 2016 -- Proof of concept studies at NBE Therapeutics demonstrated conjugation of CIS Pharma’s Cellophil® Smart Polymer drug carrier to antibodies. Consequently, different linkers were evaluated for [...]

By | Januar 1st, 2016|ADC, Cellophil|0 Comments

CIS Pharma creates novel contact lens coating technology

Bubendorf, Switzerland, November 2015 -- CIS Pharma is expanding its Cellophil® Smart Polymer platform with new bio-inspired derivatives. The derivatives are used as building blocks for the development of a [...]

By | November 1st, 2015|Cellophil, ContactlensCoating|0 Comments

CIS Pharma develops solubilization technology for hydrophobic drugs

Bubendorf, Switzerland, September 2015 -- CIS Pharma has engaged in a research program to develop a new technology platform that creates water-soluble formulations of highly hydrophobic drugs. The approach comprises [...]

By | September 1st, 2015|Cellophil, solubilization technology|0 Comments

CIS Pharma creates next generation contact lens care products

Bubendorf, Switzerland, June 2015 -- CIS Pharma is investigating novel formulations and combinations of active ingredients to improve contact lens care. With over 25 years of experience and a track [...]

By | Juni 1st, 2015|Lenscareproducts|0 Comments